Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Effects of olanzapine combined with sodium valproate on symptoms, inflammatory markers, and cognitive function in patients with bipolar disorder

Open access
Wang, Xiao, Ye, Fuyu, Zhang, Zhen, Zhang, Qigui, Li, Guanhua · 2025 · Medicine

Abstract

Bipolar disorder (BD) is a chronic mental health condition characterized by alternating manic and depressive episodes that significantly impact mood and cognitive function. Recent research has linked BD to neuroinflammation. Despite the availability of antipsychotics and mood stabilizers as standard treatments, their efficacy and side effects can vary, underscoring the need for more effective therapeutic strategies. This study aims to evaluate the combined effects of olanzapine and sodium valproate on clinical symptoms and inflammatory markers in patients with BD. A total of 80 BD patients from the Fifth People’s Hospital of Jiujiang, treated between April 2022 and April 2024, were enrolled in the study. They were divided into 2 groups: the control group, which received olanzapine monotherapy, and the observation group, which received a combination of olanzapine and sodium valproate. After 8 weeks of treatment, clinical efficacy was assessed using the Bech-Rafaelsen Mania scale and the Hamilton depression scale. Serum inflammatory markers, including interleukin-1, interleukin-10, and tumor necrosis factor-alpha, were measured along with neuroendocrine function indicators (thyroid hormone, cortisol, thyroid-stimulating hormone, and adrenocorticotropic hormone). Cognitive function was evaluated using computerized assessments, and adverse events were monitored and recorded. The observation group exhibited significantly lower Bech-Rafaelsen Mania scale and Hamilton depression scale scores, as well as reduced interleukin-1 and tumor necrosis factor-alpha levels compared to the control group. Both groups showed decreased levels of serum thyroid hormone, cortisol, and adrenocorticotropic hormone, along with increased thyroid-stimulating hormone levels after treatment, with more pronounced changes observed in the observation group ( P < .01). Additionally, cognitive function scores were significantly higher in the observation group ( P < .05), and the incidence of adverse events was lower (15.00% vs 22.50%, χ² = 0.38, P < .01). The combination of olanzapine and sodium valproate leads to significant improvements in clinical symptoms, reduces inflammatory markers, enhances cognitive function, and demonstrates greater safety compared to olanzapine monotherapy. This combination therapy offers a promising treatment approach for managing BD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000042803

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Connolly, 2011, The clinical management of bipolar disorder: a review of evidence-based guidelines., Prim Care Companion CNS Disord, 13, PCC.10r01097

Cited by

See all 5

Metadata

Authors
Wang, X., Ye, F., Zhang, Z., Zhang, Q., & Li, G.
Affiliations
  • Department of Psychological Assessment Room, Jiujiang Fifth People’s Hospital, Jiujiang, Jiangxi Province, China
  • Jiujiang First People's Hospital (CN)
  • Department of Psychiatry, The Fifth People’s Hospital of Jiujiang City, Jiujiang, Jiangxi Province, China
Corresponding author
Li, Guanhua
Venue
Medicine
Published
2025-06-27
Volume
104
Issue
26
Pages
e42803
ISSN
  • 0025-7974 (ISSN-L)
  • 1536-5964
OpenAlex
W4411789199
Cited by
5
References
35
Citations by year
2026: 4 · 2025: 1
FWCI
3.36
Type
journal article
Language
en
Open access
Locations
  • Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bipolar disorder, olanzapine, valproic acid, combination therapy, neuroinflammation, inflammatory markers, interleukin-1, IL-10, TNF-α, thyroid function, cortisol, cognitive function, mania, depression, adverse events
MeSH terms
Olanzapine, Adult, Bipolar Disorder, Cognition, Drug Therapy, Combination, Female, Humans, Inflammation, Male, Middle Aged, Psychiatric Status Rating Scales, Antipsychotic Agents, Valproic Acid, Biomarkers, Treatment Outcome, Antimanic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of olanzapine combined with sodium valproate on symptoms, inflammatory markers, and cognitive function in patients with bipolar disorder. https://app.cochat.ai/papers/10.1097/md.0000000000042803
The paper
Wang, X., Ye, F., Zhang, Z., Zhang, Q., & Li, G. (2025). Effects of olanzapine combined with sodium valproate on symptoms, inflammatory markers, and cognitive function in patients with bipolar disorder. Medicine. https://doi.org/10.1097/md.0000000000042803

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.